![Markku Tapani Jalkanen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Markku Tapani Jalkanen
Oprichter bij FARON PHARMACEUTICALS OY
Vermogen: 5 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Markku Tapani Jalkanen
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 31 | |
Subsidiary | Pharmaceuticals: Major | 3 | |
Inveni Capital Oy
![]() Inveni Capital Oy Investment ManagersFinance Inveni Capital Oy is a venture capital investment firm with offices in Helsinki and Munich. The Finnish-German firm was founded in 2007. Their investors include the Finnish Industry Investment Ltd. as largest single investor, along with other private investors and funds as well as the University of Helsinki.
2
| Private Company | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Markku Tapani Jalkanen via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
WOLFSPEED, INC. | Semiconductors | Director/Board Member | |
Human Genome Sciences, Inc.
![]() Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of Turku | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
Stick Tech Oy
![]() Stick Tech Oy Medical SpecialtiesHealth Technology Stick Tech Oy engages in the development, manufacture, and marketing of products for dental reinforcements. It offers everStickC&B, a glass fibre reinforcement for minimally invasive composite bridges. The company was founded in 1997 and is headquartered in Turku, Finland. | Medical Specialties | Director/Board Member Director/Board Member | |
Targovax Oy
![]() Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
University of Helsinki | College/University | Corporate Officer/Principal Graduate Degree | |
Medtentia International Ltd. Oy
![]() Medtentia International Ltd. Oy Medical SpecialtiesHealth Technology Medtentia International Ltd. Oy is a holding company that develops solutions for mitral valve repair based on its proprietary helix ring concept. It is a medical technology company that creates solutions for cardiac interventions. It provides proprietary, helix-shaped products to address the unmet need in cardiac surgery. The company was founded by Dan Mogren and Olli U. Keränen in 2002 by Olli Keränen and is headquartered in Espoo, Finland. | Medical Specialties | Director/Board Member Director of Finance/CFO | |
Aalto University School of Business | College/University | Graduate Degree Masters Business Admin | |
Laurantis Pharma Oy
![]() Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Dassiet Oy
![]() Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member Chairman | |
Memgen, Inc.
![]() Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Healthcare Royalty Management LLC
![]() Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Corporate Officer/Principal Founder | |
The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
Bactobio Ltd.
![]() Bactobio Ltd. BiotechnologyHealth Technology Bactobio Ltd. is a biotechnology company based in an undisclosed location. The British company uses synthetic biology, next-generation sequencing, and machine learning to cultivate previously unculturable microbes. Bactobio has exclusive access to a large bioresource, which allows them to discover novel chemical and biological products in the pharmaceutical, agricultural, and bioderived-chemical sectors. The company's first goal is to help solve the growing antimicrobial resistance crisis. Bactobio has developed a platform to culture soil bacteria that have not been culturable in the laboratory and uncover valuable secondary metabolites they produce. The company's proprietary technology combines microbiology with bioinformatics and machine learning to expand access to novel species with the potential to produce solutions across healthcare, agriculture, and industrial markets. The company was founded in 2020 by Andreas Harris and Daniel Hansen, with Daniel Hansen serving as CEO since then. | Biotechnology | Director/Board Member | |
Celgene International SARL
![]() Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Celgene Ltd.
![]() Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Celgene Europe Ltd.
![]() Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The company is based in Middlesex, UK. | Biotechnology | Director/Board Member | |
Leniobio GmbH
![]() Leniobio GmbH Miscellaneous Commercial ServicesCommercial Services Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
Touchlight Genetics Ltd.
![]() Touchlight Genetics Ltd. BiotechnologyHealth Technology Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom. | Biotechnology | Director/Board Member | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Meatless Farm Ltd.
![]() The Meatless Farm Ltd. Food: Major DiversifiedConsumer Non-Durables The Meatless Farm Ltd. produces plant-based ground and burgers. The firm’s recipes include ground, burger, sausage and BBO recipes. It also offers plant-based sausage and breakfast sausages. The company was founded by Morten Toft Bech in 2016 and is headquartered in Leeds, the United Kingdom. | Food: Major Diversified | Director/Board Member | |
Adler Ortho Srl
![]() Adler Ortho Srl Medical SpecialtiesHealth Technology Adler Ortho Srl manufacturing and wholesales orthopedic surgical prosthesis equipment. The company is headquartered in Cormano, Italy. | Medical Specialties | Director/Board Member | |
Nukute Oy
![]() Nukute Oy Medical SpecialtiesHealth Technology Nukute Oy is a Finnish company that aims to improve the diagnosis of sleep apnea. Nukute is based in Oulu, FI. The company provides a Collare system that has been evaluated for its usability and clinical performance. The company was founded by Tuukka Visuri and Toni Leinonen, with Toni Leinonen serving as the CEO since incorporation. | Medical Specialties | Director/Board Member | |
University of North Alabama | College/University | Director/Board Member | |
National Pharmaceutical Council
![]() National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman | |
KNOW Bio LLC
![]() KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Kemianteollisuus ry | Director/Board Member | ||
HealthCap VII GP SA | Director/Board Member | ||
Academy of Finland | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Stanford University | College/University | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 16 |
Finland | 14 |
Verenigd Koninkrijk | 9 |
Duitsland | 3 |
Zwitserland | 3 |
Sectoraal
Health Technology | 30 |
Consumer Services | 7 |
Commercial Services | 4 |
Electronic Technology | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 149 |
Corporate Officer/Principal | 57 |
Chairman | 45 |
Chief Executive Officer | 31 |
Independent Dir/Board Member | 30 |
Sterkste connecties
- Beurs
- Insiders
- Markku Tapani Jalkanen
- Bedrijfsconnecties